News and Updates

Time in range is a metric measured by continuous glucose monitors. Learn about why it matters and future applications.

Breakthrough T1D Ride is more than just cycling—it’s a movement to find cures for type 1 diabetes (T1D). In 2026, we were thrilled to introduce two new destinations with The Cascades, Washington and Austin, Texas. But we’re also marking the final year of Ride in beautiful Amelia Island, Florida, which means it’s your last chance […]

Golf champion J.J. Spaun discusses his game and life with T1D with dedicated Breakthrough T1D supporter Moira McCarthy.

Learn more about GLP-1 therapies and SGLT inhibitors, and how drugs like Ozempic may one day be able to help people with type 1 diabetes.

Summer is officially in full swing, which means members of the type 1 diabetes (T1D) community across the country are heading out for days at the pool, beach, or a neighborhood barbecue (check out our summer guide for all your T1D tips!). But for the Tierney family in Sacramento, summer also means it’s time for […]

What’s Happening? In an exciting update for the type 1 diabetes (T1D) community, Tzield—the first disease-modifying therapy approved by the FDA to delay progression of stage 2 T1D—has now been approved by the FDA for use in stage 3 T1D. People aged 8-17 with stage 3 T1D will soon be able to get Tzield in clinics (with a prescription) if […]

Breakthrough T1D was on site in New Orleans, LA from June 5-8 for the American Diabetes Association’s (ADA) 86th Scientific Sessions. Check out all of our coverage below, including type 1 diabetes (T1D) advances across all our mission priority areas and several Breakthrough T1D-funded researchers and staff driving progress forward. In case you missed it, […]

Breakthrough T1D is here to answer all of your questions about islet cell therapies, from the research lab to real-world treatments.

ADA’s 86th Scientific Sessions This event is one of the largest diabetes conferences in the world, bringing together over 11,000 attendees to share and learn about cutting-edge research and advancements toward cures. Each year, Breakthrough T1D-funded researchers highlight their work, demonstrating the progress we’re making toward achieving our mission. Leading experts will present over 100 […]

New data from a Breakthrough T1D–funded islet cell transplant trial shows all 12 participants are off external insulin using tegoprubart.